Tom Macleod

1.3k total citations
46 papers, 900 citations indexed

About

Tom Macleod is a scholar working on Dermatology, Immunology and Rheumatology. According to data from OpenAlex, Tom Macleod has authored 46 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 16 papers in Immunology and 12 papers in Rheumatology. Recurrent topics in Tom Macleod's work include Psoriasis: Treatment and Pathogenesis (12 papers), Contact Dermatitis and Allergies (7 papers) and Skin Protection and Aging (7 papers). Tom Macleod is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), Contact Dermatitis and Allergies (7 papers) and Skin Protection and Aging (7 papers). Tom Macleod collaborates with scholars based in United Kingdom, Israel and Germany. Tom Macleod's co-authors include Dennis McGonagle, Miriam Wittmann, W. FRAIN-BELL, Martin Stacey, Charlie Bridgewood, E.J. Raffle, F Hutchinson, Joseph S. Ainscough, Adewonuola Alase and Jens Malte Baron and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Journal of Chromatography A.

In The Last Decade

Tom Macleod

42 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Macleod United Kingdom 18 418 349 171 134 92 46 900
Muneo Ohkido Japan 20 453 1.1× 550 1.6× 182 1.1× 116 0.9× 151 1.6× 73 1.1k
Masato Kakeda Japan 13 316 0.8× 252 0.7× 144 0.8× 71 0.5× 71 0.8× 22 686
Michiyuki Koga Japan 14 218 0.5× 241 0.7× 135 0.8× 81 0.6× 51 0.6× 41 750
Heidi Goodarzi United States 10 456 1.1× 431 1.2× 198 1.2× 125 0.9× 128 1.4× 14 1.3k
Jinrong Zeng China 17 225 0.5× 429 1.2× 310 1.8× 135 1.0× 100 1.1× 58 1.1k
Annunziata Dattola Italy 17 485 1.2× 371 1.1× 108 0.6× 112 0.8× 141 1.5× 75 920
Serena Lembo Italy 22 653 1.6× 560 1.6× 166 1.0× 124 0.9× 125 1.4× 65 1.2k
Roberta Di Caprio Italy 16 382 0.9× 382 1.1× 136 0.8× 87 0.6× 91 1.0× 37 824
Federico Diotallevi Italy 17 349 0.8× 272 0.8× 85 0.5× 84 0.6× 123 1.3× 69 758
Sari Suomela Finland 21 394 0.9× 474 1.4× 295 1.7× 79 0.6× 121 1.3× 46 1.3k

Countries citing papers authored by Tom Macleod

Since Specialization
Citations

This map shows the geographic impact of Tom Macleod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Macleod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Macleod more than expected).

Fields of papers citing papers by Tom Macleod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Macleod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Macleod. The network helps show where Tom Macleod may publish in the future.

Co-authorship network of co-authors of Tom Macleod

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Macleod. A scholar is included among the top collaborators of Tom Macleod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Macleod. Tom Macleod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meridor, Katya, Jane Freeston, Philip Laws, et al.. (2025). Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis. Lara D. Veeken. 65(3).
2.
3.
Macleod, Tom, et al.. (2025). Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy. The Lancet Rheumatology. 7(4). e290–e302. 2 indexed citations
4.
Macleod, Tom, et al.. (2024). Epidermal proteomics demonstrates Elafin as a psoriasis‐specific biomarker and highlights increased anti‐inflammatory activity around psoriatic plaques. Journal of the European Academy of Dermatology and Venereology. 39(7). 1324–1335. 1 indexed citations
5.
Macleod, Tom, et al.. (2024). How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders. Frontiers in Immunology. 15. 1439371–1439371. 8 indexed citations
6.
Clifton, I., et al.. (2023). Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis. RMD Open. 9(4). e003583–e003583. 4 indexed citations
7.
McGonagle, Dennis, Paula David, Tom Macleod, & ‬‬‬‬Abdulla Watad. (2023). Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis. Nature Reviews Rheumatology. 19(12). 818–827. 30 indexed citations
8.
Bridgewood, Charlie, Miriam Wittmann, Tom Macleod, et al.. (2022). T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases. Journal of Investigative Dermatology. 142(10). 2660–2667. 74 indexed citations
9.
Macleod, Tom, et al.. (2021). The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier. Frontiers in Immunology. 12. 808012–808012. 53 indexed citations
10.
Macleod, Tom, Joseph S. Ainscough, Christina Hesse, et al.. (2020). The Proinflammatory Cytokine IL-36γ Is a Global Discriminator of Harmless Microbes and Invasive Pathogens within Epithelial Tissues. Cell Reports. 33(11). 108515–108515. 39 indexed citations
11.
12.
Bridgewood, Charlie, Gareth W. Fearnley, Philip Laws, et al.. (2018). IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis. Frontiers in Immunology. 9. 200–200. 71 indexed citations
13.
Macleod, Tom, Dennis McGonagle, Christopher W. Wasson, et al.. (2016). Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist. Scientific Reports. 6(1). 24880–24880. 81 indexed citations
14.
Macleod, Tom, et al.. (2003). Wound swabbing technique.. PubMed. 99(5). 57–9. 9 indexed citations
15.
Macleod, Tom, et al.. (1997). Bath PUVA – an investigation of the distribution of trioxsalen (TMP) and 8‐methoxypsoralen (8‐MOP) in bathwater. Photodermatology Photoimmunology & Photomedicine. 13(1-2). 17–20. 1 indexed citations
16.
Dawe, Robert, et al.. (1996). Daisy, dandelion and thistle contact allergy in the photosensitivity dermatitis and actinic reticuloid syndrome. Contact Dermatitis. 35(2). 109–110. 18 indexed citations
17.
18.
Macleod, Tom, et al.. (1989). Polymorphonuclear Leucocyte Chemotaxis in Response to Leukotriene B<sub>4</sub> in Treated and Untreated Psoriatics. Dermatology. 178(1). 20–22. 2 indexed citations
19.
Macleod, Tom, et al.. (1989). HPLC STUDIES ON THE DEGRADATION PROFILES OF GLUCOSE 5% SOLUTIONS SUBJECTED TO HEAT STERILIZATION IN A MICROPROCESSOR-CONTROLLED AUTOCLAVE. Journal of Clinical Pharmacy and Therapeutics. 14(3). 189–195. 16 indexed citations
20.
Wright, M. Jerry, I.S. Grant, & Tom Macleod. (1985). Drug dilution in anaesthetic practice. Anaesthesia. 40(3). 298–299. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muneo Ohkido Breakdown of academic impact, for papers by Masato Kakeda Breakdown of academic impact, for papers by Michiyuki Koga Breakdown of academic impact, for papers by Heidi Goodarzi Breakdown of academic impact, for papers by Jinrong Zeng Breakdown of academic impact, for papers by Annunziata Dattola Breakdown of academic impact, for papers by Serena Lembo Breakdown of academic impact, for papers by Roberta Di Caprio Breakdown of academic impact, for papers by Federico Diotallevi Breakdown of academic impact, for papers by Sari Suomela
Rankless by CCL
2026